Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients

OBJECTIVE: Fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients has recently emerged important social health topic. This study is designed to explore the risk factors for time to complete remission (CR) of fertility-sparing treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Yingqiao, Fan, Yuan, Li, Xingchen, Wang, Yiqin, Wang, Jianliu, Tian, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442985/
https://www.ncbi.nlm.nih.gov/pubmed/36064542
http://dx.doi.org/10.1186/s12958-022-01006-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442985/
https://www.ncbi.nlm.nih.gov/pubmed/36064542
http://dx.doi.org/10.1186/s12958-022-01006-0

Ejemplares similares